NLS Pharmaceutics AG (NLSP) - Winst- en verliesrekening per kwartaal

Home
NLSP
Financiële Gegevens

4.15 (USD) • At close November 7, 2024

Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

	2024 Q2	2023 Q4	2023 Q2	2022 Q4	2022 Q2	2021 Q4	2021 Q2	2020 Q4	2020 Q2	2019 Q4	2019 Q2	2018 Q4	2018 Q2	2018 Q1	2017 Q2	2017 Q1
Omzet Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Kosten van de omzet Numbers are in millions	0.006	0.006	0.006	0.006	0.006	0.005	0.005	0	0	0	0	0	0	0	0	0
Brutowinst Numbers are in millions	-0.006	-0.006	-0.006	-0.006	-0.006	-0.005	-0.005	0	0	0	0	0	0	0	0	0
Brutowinstmarge Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Onderzoek- en ontwikkelingskosten Numbers are in millions	0.271	0.002	4.384	3.433	5.544	4.057	1.863	0	0.161	0.722	0.98	0	0.001	0.359	1.081	1.081
Algemene en administratieve kosten Numbers are in millions	0	0.003	0.003	0.003	0.003	0.003	0.003	0.001	0.001	0.002	0.001	0.002	0.001	0.503	0.36	0.36
Verkoop- en marketingkosten Numbers are in millions	0	2.724	3.157	3.353	3.135	3.253	2.672	1.217	0.92	1.246	1.245	0	0	0	0	0
Verkoop-, algemene en administratieve kosten Numbers are in millions	1.776	0.003	3.16	3.356	3.138	3.256	2.675	1.218	0.921	1.248	1.247	0.002	0.001	0.503	0.36	0.36
Overige kosten Numbers are in millions	0	0	0	0	0	1.21	0	1.21	0	0	0	0	-1.724	-1.724	-2.883	-2.883
Bedrijfskosten Numbers are in millions	2.048	0.004	7.544	6.789	8.682	7.313	4.538	1.218	1.082	1.971	2.226	0.003	0.002	-0.862	-1.442	-1.442
Bedrijfsresultaat Numbers are in millions	-2.053	-0.004	-7.549	-6.794	-8.688	-7.318	-4.543	-1.218	-1.082	-1.971	-2.226	-0.002	-0.002	-0.862	-1.442	-1.442
Bedrijfsresultaat ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Totaal overige inkomsten en kosten netto Numbers are in millions	0.018	-0	-0.063	-1.061	0.047	-0.025	-0.061	-0.412	-0.151	-0.061	-1.189	-0.001	-0.001	-0.424	-0.223	-0.223
Inkomen voor belasting Numbers are in millions	-2.036	-0.005	-7.613	-7.855	-8.641	-7.343	-4.603	-1.629	-1.232	-2.032	-3.415	-0.003	-0.002	-1.287	-1.664	-1.664
Inkomen voor belasting ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Belastingkosten Numbers are in millions	0.105	-0	-0	-0	-0	0	-0	0	-0.001	-0.002	-0.002	-0.001	-0.001	0	0	0
Nettowinst Numbers are in millions	-2.036	-0.005	-7.613	-7.855	-8.641	-7.343	-4.603	-1.629	-1.232	-2.032	-3.415	-0.003	-0.002	-1.287	-1.664	-1.664
Nettowinstmarge Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
WPA (Winst Per Aandeel) Numbers are in millions	-0.049	-0.141	-0.2	-0.29	-0.54	-0.5	-0.42	-0.34	-0.11	-0.18	-0.31	-0.276	-0.186	-0.12	-0.16	-0.16
Verwaterde WPA Numbers are in millions	-0.049	-0.141	-0.2	-0.29	-0.54	-0.5	-0.42	-0.34	-0.11	-0.18	-0.31	-0.276	-0.186	-0.12	-0.16	-0.16
EBITDA Numbers are in millions	-1.943	-0.004	-7.544	-6.789	-8.682	-7.313	-4.538	-1.218	-1.082	-1.971	-2.226	-0.001	-0.001	-1.02	-1.442	-1.442
EBITDA ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

NLS Pharmaceutics AG

NASDAQ:NLSP Add to watchlist

NASDAQ:NLSP